Another day, another multibillion pharma deal - part 2

Saturday, 19 July 2014, 7:38 pm

Now that the £32 billion AbbVie/Shire deal looks to be "done" (or at least for the time being), it's time to look at another potential deal brewing in the sector.

I hear GlaxoSmithKline is in the early stages of examining a multi-billion dollar takeover bid for US-based biopharmaceutical company InterMune.

Good sources tell me the FTSE 100 giant has spent the last month looking at whether to make an offer for InterMune, which specialises in making a drug to treat idiopathic pulmonary fibrosis...


Register for free to see rest of this article and all public articles from Betaville

Login / Register

[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Post Comment